Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
<p>Supplementary Table S2</p>
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , , , , , , , , , |
| Veröffentlicht: |
2025
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1849927637579857920 |
|---|---|
| author | Phyllis S.Y. Chong (17141520) |
| author2 | Jing-Yuan Chooi (17141523) Julia S.L. Lim (17141526) Aaron C.Y. Leow (17141529) Sabrina Hui Min Toh (17141532) Irfan Azaman (17141535) Mun Yee Koh (17141538) Phaik Ju Teoh (17141541) Tuan Zea Tan (14952532) Tae-Hoon Chung (17141544) Wee Joo Chng (14959944) |
| author2_role | author author author author author author author author author author |
| author_facet | Phyllis S.Y. Chong (17141520) Jing-Yuan Chooi (17141523) Julia S.L. Lim (17141526) Aaron C.Y. Leow (17141529) Sabrina Hui Min Toh (17141532) Irfan Azaman (17141535) Mun Yee Koh (17141538) Phaik Ju Teoh (17141541) Tuan Zea Tan (14952532) Tae-Hoon Chung (17141544) Wee Joo Chng (14959944) |
| author_role | author |
| dc.creator.none.fl_str_mv | Phyllis S.Y. Chong (17141520) Jing-Yuan Chooi (17141523) Julia S.L. Lim (17141526) Aaron C.Y. Leow (17141529) Sabrina Hui Min Toh (17141532) Irfan Azaman (17141535) Mun Yee Koh (17141538) Phaik Ju Teoh (17141541) Tuan Zea Tan (14952532) Tae-Hoon Chung (17141544) Wee Joo Chng (14959944) |
| dc.date.none.fl_str_mv | 2025-11-24T23:25:20Z |
| dc.identifier.none.fl_str_mv | 10.1158/0008-5472.30701416 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Histone_Methyltransferase_NSD2_Activates_PKC_to_Drive_Metabolic_Reprogramming_and_Lenalidomide_Resistance_in_Multiple_Myeloma/30701416 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Clinical drug resistance Epigenetics Histone Modification Metabolism Metabolomics |
| dc.title.none.fl_str_mv | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Supplementary Table S2</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_89cd9c6a4cefc7d63b7977ef6157fe52 |
| identifier_str_mv | 10.1158/0008-5472.30701416 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30701416 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple MyelomaPhyllis S.Y. Chong (17141520)Jing-Yuan Chooi (17141523)Julia S.L. Lim (17141526)Aaron C.Y. Leow (17141529)Sabrina Hui Min Toh (17141532)Irfan Azaman (17141535)Mun Yee Koh (17141538)Phaik Ju Teoh (17141541)Tuan Zea Tan (14952532)Tae-Hoon Chung (17141544)Wee Joo Chng (14959944)CancerCancer Risk FactorsMolecular and Cellular BiologyTherapeutic Research and DevelopmentDrug ResistanceClinical drug resistanceEpigeneticsHistone ModificationMetabolismMetabolomics<p>Supplementary Table S2</p>2025-11-24T23:25:20ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30701416https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Histone_Methyltransferase_NSD2_Activates_PKC_to_Drive_Metabolic_Reprogramming_and_Lenalidomide_Resistance_in_Multiple_Myeloma/30701416CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307014162025-11-24T23:25:20Z |
| spellingShingle | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma Phyllis S.Y. Chong (17141520) Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Clinical drug resistance Epigenetics Histone Modification Metabolism Metabolomics |
| status_str | publishedVersion |
| title | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| title_full | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| title_fullStr | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| title_full_unstemmed | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| title_short | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| title_sort | Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma |
| topic | Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Drug Resistance Clinical drug resistance Epigenetics Histone Modification Metabolism Metabolomics |